532067 — 3B Blackbio DX Income Statement
0.000.00%
- IN₹12.84bn
- IN₹12.18bn
- IN₹964.69m
- 98
- 15
- 23
- 42
Annual income statement for 3B Blackbio DX, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,267 | 806 | 618 | 741 | 965 |
Cost of Revenue | |||||
Gross Profit | 1,752 | 490 | 439 | 523 | 708 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 774 | 442 | 336 | 422 | 474 |
Operating Profit | 1,494 | 364 | 283 | 319 | 490 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,520 | 432 | 353 | 443 | 640 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,139 | 322 | 259 | 321 | 477 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,139 | 322 | 259 | 321 | 477 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,139 | 322 | 259 | 321 | 477 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 152 | 43 | 30.3 | 37.5 | 55.7 |
Dividends per Share | |||||
Special Dividends per Share |